So to explain this story, you have to go to the trial situation and how the AstraZeneca built the testing subject group.
Eight-percent of the group were over 65....that's it. The 92-percent left? Between ages 18 and 65. That was the initial test situation, and that was what the Germans went with....when building the rules.
The Daily Mail talked to this topic a good bit and is worth a read.
If you are a German, 66 years old, and now have access to AstraZeneca? Your doctor won't give it to you.
Newer test group data? Well...yeah, and with higher numbers of people over 65, with all positive results. The odds that the Germans will update their vaccination rules? Normally, I'd suggest that within thirty days....they'd review the data and change the rules. Right now? There's so much anti-Brit attitude....I doubt if they will change the rules for at least six months (my humble feeling).
An amusing childish game? Well....the EU went to the next step of saying no export license will be issued for AstraZeneca production folks in Belgium until all orders for EU customers are done. Even if the contracts signed with non-EU members exist, with higher payments and higher priorities in the mix? Yeah. In simple terms, if AstraZeneca misses on delivery because of this (to a non-EU customer), then it'll go to court action. Figure two to three years, and somewhere down the line....some half-billion Euro damage situation will occur with the EU paying a massive fine.
You can laugh over this whole game, but it would serve the EU well now....to bring in a number of new faces from Greece, Denmark, or Portugal....and retire out the folks with Britain constantly on their mind.
The next EU election? Not until 2024.
No comments:
Post a Comment